Plus Therapeutics Relocates Principal Executive Offices

Ticker: PSTV · Form: 8-K · Filed: Nov 1, 2024 · CIK: 1095981

Plus Therapeutics, Inc. 8-K Filing Summary
FieldDetail
CompanyPlus Therapeutics, Inc. (PSTV)
Form Type8-K
Filed DateNov 1, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001, $2.5 million, $35 million, $500,000
Sentimentneutral

Sentiment: neutral

Topics: corporate-action, address-change

TL;DR

PLUS THERAPEUTICS moved its main office to Austin, TX effective Oct 30.

AI Summary

On October 30, 2024, PLUS THERAPEUTICS, INC. (formerly CYTORI THERAPEUTICS, INC. and MACROPORE INC) filed an 8-K report. The filing indicates a change in the company's principal executive offices to 4200 Marathon Blvd., Suite 200, Austin, Texas 78756. This move is effective as of October 30, 2024.

Why It Matters

A change in principal executive offices can signal operational shifts or strategic realignments within a company.

Risk Assessment

Risk Level: low — This filing primarily concerns a change of address for the company's principal executive offices, which is a routine administrative event.

Key Players & Entities

  • PLUS THERAPEUTICS, INC. (company) — Registrant
  • CYTORI THERAPEUTICS, INC. (company) — Former company name
  • MACROPORE INC (company) — Former company name
  • October 30, 2024 (date) — Date of earliest event reported
  • 4200 Marathon Blvd., Suite 200, Austin, Texas 78756 (location) — New principal executive offices address

FAQ

What is the new address for PLUS THERAPEUTICS, INC.'s principal executive offices?

The new address is 4200 Marathon Blvd., Suite 200, Austin, Texas 78756.

When was the change in principal executive offices effective?

The change was effective as of October 30, 2024.

What were the former names of PLUS THERAPEUTICS, INC. mentioned in the filing?

The filing mentions former names of CYTORI THERAPEUTICS, INC. and MACROPORE INC.

What is the state of incorporation for PLUS THERAPEUTICS, INC.?

The company is incorporated in Delaware.

What is the company's IRS Employer Identification Number?

The IRS Employer Identification Number is 33-0827593.

Filing Stats: 616 words · 2 min read · ~2 pages · Grade level 11.8 · Accepted 2024-11-01 08:25:54

Key Financial Figures

  • $0.001 — ich registered Common Stock, par value $0.001 PSTV The Nasdaq Capital Market Ind
  • $2.5 million — ule 5550(b)(1) to maintain a minimum of $2.5 million in stockholders' equity (the "Minimum S
  • $35 million — a market value of listed securities of $35 million or net income from continuing operation
  • $500,000 — et income from continuing operations of $500,000 in the most recently completed fiscal y

Filing Documents

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: November 1, 2024 PLUS THERAPEUTICS, INC. By: /s/ Marc H. Hedrick, M.D. Marc H. Hedrick, M.D. President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.